Gilead Sciences, Inc. (BIT:1GILD)
Italy · Delayed Price · Currency is EUR 106.58
-0.04 (-0.04%)
At close: Dec 4, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €129.28 billion as of December 5, 2025. Its market cap has increased by 25.17% in one year.
Market Cap
129.28B
Enterprise Value
141.63B
Revenue
24.79B
Ranking
n/a
PE Ratio
18.70
Stock Price
€106.58
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 129.28B, an increase of 66,374.95%. That is a compound annual growth rate of 21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 129.28B | 16.27% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | 59.70B | -18.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.12B |
| DiaSorin | 3.26B |
| Amplifon | 2.91B |
| EL.En. | 1.03B |
| Philogen | 946.21M |
| Safilo Group | 767.17M |
| Pharmanutra | 547.39M |
| GPI S.p.A. | 494.57M |